Marc A Probst1, Alexander T Janke2, Adrian D Haimovich2, Arjun K Venkatesh2, Michelle P Lin3, Keith E Kocher4, Marie-Joe Nemnom5, Venkatesh Thiruganasambandamoorthy6. 1. Department of Emergency Medicine, Columbia University Medical Center, New York, NY. Electronic address: mprobst@gmail.com. 2. Department of Emergency Medicine, Yale School of Medicine, New Haven, CT. 3. Department of Emergency Medicine and Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY. 4. Department of Emergency Medicine and Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI. 5. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 6. Department of Emergency Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Abstract
STUDY OBJECTIVE: Emergency department (ED) evaluations for syncope are common, representing 1.3 million annual US visits and $2 billion in related hospitalizations. Despite evidence supporting risk stratification and outpatient management, variation in syncope hospitalization rates persist. We sought to develop a new quality measure for very low-risk adult ED patients with syncope that could be applied to administrative data. METHODS: We developed this quality measure in 2 phases. First, we used an existing prospective, observational ED patient data set to identify a very low-risk cohort with unexplained syncope using 2 variables: age less than 50 years and no history of heart disease. We then applied this to the 2019 Nationwide Emergency Department Sample (NEDS) to assess its potential effect, assessing for hospital-level factors associated with hospitalization variation. RESULTS: Of the 8,647 adult patients in the prospective cohort, 3,292 (38%) patients fulfilled these 2 criteria: age less than 50 years and no history of heart disease. Of these, 15 (0.46%) suffered serious adverse events within 30 days. In the NEDS, there were an estimated 566,031 patients meeting these 2 criteria, of whom 15,507 (2.7%; 95% confidence interval [CI] 2.48% to 3.00%) were hospitalized. We found substantial variation in the hospitalization rates for this very low-risk cohort, with a median rate of 1.7% (range 0% to 100%; interquartile range 0% to 3.9%). Factors associated with increased hospitalization rates included a yearly ED volume of more than 80,000 (odds ratio [OR] 3.14; 95% CI 2.02 to 4.89) and metropolitan teaching status (OR 1.5; 95% CI 1.24 to 1.81). CONCLUSION: In summary, our novel syncope quality measure can assess variation in low-value hospitalizations for unexplained syncope. The application of this measure could improve the value of syncope care.
STUDY OBJECTIVE: Emergency department (ED) evaluations for syncope are common, representing 1.3 million annual US visits and $2 billion in related hospitalizations. Despite evidence supporting risk stratification and outpatient management, variation in syncope hospitalization rates persist. We sought to develop a new quality measure for very low-risk adult ED patients with syncope that could be applied to administrative data. METHODS: We developed this quality measure in 2 phases. First, we used an existing prospective, observational ED patient data set to identify a very low-risk cohort with unexplained syncope using 2 variables: age less than 50 years and no history of heart disease. We then applied this to the 2019 Nationwide Emergency Department Sample (NEDS) to assess its potential effect, assessing for hospital-level factors associated with hospitalization variation. RESULTS: Of the 8,647 adult patients in the prospective cohort, 3,292 (38%) patients fulfilled these 2 criteria: age less than 50 years and no history of heart disease. Of these, 15 (0.46%) suffered serious adverse events within 30 days. In the NEDS, there were an estimated 566,031 patients meeting these 2 criteria, of whom 15,507 (2.7%; 95% confidence interval [CI] 2.48% to 3.00%) were hospitalized. We found substantial variation in the hospitalization rates for this very low-risk cohort, with a median rate of 1.7% (range 0% to 100%; interquartile range 0% to 3.9%). Factors associated with increased hospitalization rates included a yearly ED volume of more than 80,000 (odds ratio [OR] 3.14; 95% CI 2.02 to 4.89) and metropolitan teaching status (OR 1.5; 95% CI 1.24 to 1.81). CONCLUSION: In summary, our novel syncope quality measure can assess variation in low-value hospitalizations for unexplained syncope. The application of this measure could improve the value of syncope care.
Authors: James V Quinn; Ian G Stiell; Daniel A McDermott; Karen L Sellers; Michael A Kohn; George A Wells Journal: Ann Emerg Med Date: 2004-02 Impact factor: 5.721
Authors: Matthew J Reed; David E Newby; Andrew J Coull; Robin J Prescott; Keith G Jacques; Alasdair J Gray Journal: J Am Coll Cardiol Date: 2010-02-23 Impact factor: 24.094
Authors: Win K Shen; Wyatt W Decker; Peter A Smars; Deepi G Goyal; Ann E Walker; David O Hodge; Jane M Trusty; Karen M Brekke; Arshad Jahangir; Peter A Brady; Thomas M Munger; Bernard J Gersh; Stephen C Hammill; Robert L Frye Journal: Circulation Date: 2004-11-09 Impact factor: 29.690
Authors: Nihar R Desai; Joseph S Ross; Ji Young Kwon; Jeph Herrin; Kumar Dharmarajan; Susannah M Bernheim; Harlan M Krumholz; Leora I Horwitz Journal: JAMA Date: 2016-12-27 Impact factor: 56.272
Authors: Marc A Probst; William R Mower; Hemal K Kanzaria; Jerome R Hoffman; Eric F Buch; Benjamin C Sun Journal: Am J Cardiol Date: 2014-03-01 Impact factor: 2.778
Authors: Marc A Probst; Thomas Gibson; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Judd E Hollander; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun Journal: Ann Emerg Med Date: 2019-10-23 Impact factor: 5.721
Authors: Marc A Probst; John K McConnell; Robert E Weiss; Amber L Laurie; Annick N Yagapen; Michelle P Lin; Jeffrey M Caterino; Manish N Shah; Benjamin C Sun Journal: West J Emerg Med Date: 2017-01-20